Alendronate is a bisphosphonate medication that reduces bone destruction by bone cells known as osteoclasts and subsequently increasing bone density. Studies have shown limited successful results in the management of the early stages of the AVN. Unfortunately, most patients progress to an advanced stage without surgical intervention.